ClinConnect ClinConnect Logo
Search / Trial NCT06460870

Effect of Mojzisova Method on Pain, Menstrual Symptom and Insomnia in PD

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jun 11, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Insomnia Menstrual Symptom Pain Primary Dysmenorrhea Stretching

ClinConnect Summary

This clinical trial is studying the Mojzisova Method to see if it can help reduce pain, menstrual symptoms, and insomnia in women suffering from primary dysmenorrhea, which is severe menstrual pain. The trial will involve women aged 18 to 45 who have experienced recurrent menstrual pain for at least three cycles and find it hard to carry out their daily activities. To be eligible, participants should not have any blood problems or specific diseases that could affect the results.

Participants in the trial will be divided into two groups. One group will receive the Mojzisova Method along with standard treatment, while the other group will do stretching exercises along with the same standard treatment. Over three months, they will attend two sessions each month, where their pain and sleep quality will be assessed. This study aims to find out if the Mojzisova Method is more effective than stretching exercises in improving the symptoms of primary dysmenorrhea. If you or someone you know fits the eligibility criteria and is interested in participating, this could be an opportunity to explore new ways to manage menstrual pain.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Pain must be recurrent (at least following three menstrual cycles).
  • No history of any blood problems, such as thalassemia, folate insufficiency, or anemia due to a lack of iron. Five criteria to fulfill to be considered primary dysmenorrhea.
  • Hypogastrium pain during menstruation.
  • Irradiation of pain to lower back, lower limbs or lingual region.
  • Inability to perform daily activity.
  • The need for medical management or self-medication to control pain Nulliparous women with primary dysmenorrhea.
  • Exclusion Criteria:
  • Female with history of any specific disease.
  • Female with endocrine disorders.
  • Had gone major surgery.
  • Diagnosis of secondary dysmenorrhea.
  • Having symptoms such as numbness and tingling sensation.

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Toba Tek Singh, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Syed Shakeel Ur Rehman, Phd

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported